These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7471152)

  • 21. Assessment of alpha-fetoprotein in chronic HBsAg carriers and in HBsAg negative cirrhosis of the liver.
    Stránský J; Zichová M; Vodák M
    Sb Lek; 1993; 94(4):311-5. PubMed ID: 7527585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B.
    Arase Y; Ikeda K; Suzuki F; Suzuki Y; Saitoh S; Kobayashi M; Akuta N; Someya T; Hosaka T; Sezaki H; Kobayashi M; Kumada H
    Am J Med; 2006 Jan; 119(1):71.e9-16. PubMed ID: 16431195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis.
    Chung HT; Lai CL; Lok AS
    Hepatology; 1995 Jul; 22(1):25-9. PubMed ID: 7601418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfa. European Concerted Action on Viral Hepatitis (EUROHEP).
    Fattovich G; Giustina G; Realdi G; Corrocher R; Schalm SW
    Hepatology; 1997 Nov; 26(5):1338-42. PubMed ID: 9362381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical pathological conference: alcoholism with HBsAg, cirrhosis and Fahr's disease (author's transl)].
    De Prez C; Reding P
    Rev Med Brux; 1980 Nov; 1(9):571-8. PubMed ID: 7455424
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of ras and c-myc oncoproteins and hepatitis B surface antigen in human liver disease.
    Tiniakos D; Spandidos DA; Yiagnisis M; Tiniakos G
    Hepatogastroenterology; 1993 Feb; 40(1):37-40. PubMed ID: 8462926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between viral hepatitis B and liver cirrhosis and carcinoma.
    Dong J; Zhou MH; Ye YL
    Chin Med J (Engl); 1980 Oct; 93(10):712-6. PubMed ID: 6778669
    [No Abstract]   [Full Text] [Related]  

  • 29. [Evolution of chronic diffuse liver diseases treated by essential choline phospholipid therapy. Clinical and analytical control through exploration with radioactive isotopes].
    Galán Navarro JL
    Rev Esp Enferm Apar Dig; 1967 Apr; 26(4):460-90. PubMed ID: 5603013
    [No Abstract]   [Full Text] [Related]  

  • 30. [Humoral immunity in chronic liver disease (author's transl)].
    Sacristán MV; San Miguel G; de las Heras G; Rodríguez de Lope C; Pons Romero F
    Med Clin (Barc); 1982 Mar 1-15; 78(5):169-72. PubMed ID: 7078305
    [No Abstract]   [Full Text] [Related]  

  • 31. [Some epidemiologic characteristics of HBsAg in saliva (author's transl)].
    Jing Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 1980 May; 14(2):109-11. PubMed ID: 7215029
    [No Abstract]   [Full Text] [Related]  

  • 32. Expression of insulin-like growth factor II in chronic hepatitis B, liver cirrhosis, and hepatocellular carcinoma.
    Seo JH; Park BC
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():292-307. PubMed ID: 7661600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinico-epidemiologic aspects of hepatic cirrhosis in Campania. Relevance of the compensated forms].
    Cozzolino G; Francica G; Lonardo A; Lucariello A; Morante R; Cerini R; Cacciatore L
    Minerva Dietol Gastroenterol; 1986; 32(1):73-8. PubMed ID: 3703322
    [No Abstract]   [Full Text] [Related]  

  • 34. [Liver transplantation in HBsAg-positive patients: does preventive immune treatment improve prognosis?].
    Erhard J; Layer P
    Z Gastroenterol; 1993 Apr; 31(4):267-8. PubMed ID: 8493809
    [No Abstract]   [Full Text] [Related]  

  • 35. [Liver function tests in the haemophiliacs (author's transl)].
    Sangre (Barc); 1978; 23(5B):774-9. PubMed ID: 725717
    [No Abstract]   [Full Text] [Related]  

  • 36. Hepatic histology in chronic liver disease in hepatitis B surface antigen positive cases.
    Ghosh AK; Dasgupta A; Raha K; Jana A; Majumdar DN
    J Indian Med Assoc; 1994 Oct; 92(10):333-5. PubMed ID: 7822848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
    Mwangi J; Gatei DG
    East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Discharge of HBsAg in saliva and its epidemiological significance (author's transl)].
    Ma WG
    Zhonghua Yu Fang Yi Xue Za Zhi; 1981 Sep; 15(5):307-9. PubMed ID: 7341114
    [No Abstract]   [Full Text] [Related]  

  • 39. Occult HBV infection in cryptogenic liver cirrhosis in an area with high prevalence of HBV infection.
    Chan HL; Tsang SW; Leung NW; Tse CH; Hui Y; Tam JS; Chan FK; Sung JJ
    Am J Gastroenterol; 2002 May; 97(5):1211-5. PubMed ID: 12014730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
    Szczepański W
    Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.